Analogue X
ID: ALA606550
PubChem CID: 46878348
Max Phase: Preclinical
Molecular Formula: C22H46N6O9
Molecular Weight: 538.64
Molecule Type: Small molecule
Associated Items:
This compound is not in our inventory system
ID: ALA606550
PubChem CID: 46878348
Max Phase: Preclinical
Molecular Formula: C22H46N6O9
Molecular Weight: 538.64
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NCCCNCC[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H](O)[C@H](N)C[C@H](N)[C@H]2O[C@H]2O[C@H](CN)[C@H](O)[C@H](O)[C@H]2N)O[C@@H]1CO
Standard InChI: InChI=1S/C22H46N6O9/c23-3-1-4-28-5-2-9-13(8-29)35-22(15(9)30)37-20-16(31)10(25)6-11(26)19(20)36-21-14(27)18(33)17(32)12(7-24)34-21/h9-22,28-33H,1-8,23-27H2/t9-,10-,11+,12-,13-,14-,15-,16+,17+,18-,19-,20+,21-,22+/m1/s1
Standard InChI Key: CEXPNNVGSBVLNC-SRLPDXGBSA-N
Molfile:
RDKit 2D 37 39 0 0 0 0 0 0 0 0999 V2000 -4.3018 0.6723 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.9692 0.1874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.7143 -0.5972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.8893 -0.5972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.6344 0.1874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.1992 -1.2646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.4044 -1.2646 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -5.7538 0.4423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8497 0.4423 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.2669 1.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6795 2.4013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5045 2.4013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.9170 1.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.5045 0.9723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6795 0.9723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.7420 1.6868 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.1545 2.4013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.7420 3.1157 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.1545 3.8302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.9795 3.8302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.3920 3.1158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.9795 2.4013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.3920 1.6868 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.2670 0.2578 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.4419 1.6868 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.9170 3.1157 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -3.7420 4.5447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.3920 4.5447 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -6.2170 3.1158 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.1545 5.2592 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -6.3669 -0.1097 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -4.8637 -2.0183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.3486 -2.6858 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -5.0130 -3.4394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.4979 -4.1069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.1624 -4.8605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.6473 -5.5280 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 1 5 1 0 2 3 1 0 3 4 1 0 4 5 1 0 3 6 1 6 4 7 1 6 2 8 1 1 5 9 1 1 10 11 1 0 15 10 1 0 11 12 1 0 12 13 1 0 13 14 1 0 14 15 1 0 14 9 1 6 13 16 1 6 17 16 1 6 17 18 1 0 22 17 1 0 18 19 1 0 19 20 1 0 20 21 1 0 21 22 1 0 22 23 1 6 15 24 1 6 10 25 1 1 12 26 1 1 19 27 1 1 20 28 1 1 21 29 1 1 27 30 1 0 8 31 1 0 6 32 1 0 32 33 1 0 33 34 1 0 34 35 1 0 35 36 1 0 36 37 1 0 M END
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 538.64 | Molecular Weight (Monoisotopic): 538.3326 | AlogP: -6.07 | #Rotatable Bonds: 12 |
Polar Surface Area: 280.20 | Molecular Species: BASE | HBA: 15 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.64 | CX Basic pKa: 10.37 | CX LogP: -6.66 | CX LogD: -14.98 |
Aromatic Rings: ┄ | Heavy Atoms: 37 | QED Weighted: 0.10 | Np Likeness Score: 1.30 |
1. Cashman DJ, Rife JP, Kellogg GE.. (2001) Which aminoglycoside ring is most important for binding? A hydropathic analysis of gentamicin, paromomycin, and analogues., 11 (2): [PMID:11206440] [10.1016/s0960-894x(00)00615-6] |
Source(1):